US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

1  2    4    6  7  8  9  10  
Hospital Care Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Proplex Technologies, Llc - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... the effectiveness of cancer treatment. Proplex Technologies's 2D HPLE technology is a two-dimensional polyacrylamide gel electrophoresis used in applications to identify critical biomarkers in several human diseases. The company's technology is also used in identifying ...  |  read more...
USD 750
Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics
8/1/2014 | published by: Current Partnering
... agreements entered into by the worlds leading life science companies. The report provides a detailed understand and analysis of how and why companies enter collaborative R&D deals. Understanding the flexibility of a prospective partner’s negotiated ...  |  read more...
USD 2,995
Co-development Terms & Agreements in Pharma, Biotech and Diagnostics
8/1/2014 | published by: Current Partnering
... by the worlds leading life science companies. The report provides a detailed understand and analysis of how and why companies enter co-development deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical ...  |  read more...
USD 2,995
Cancer Monoclonal Antibody Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... healthcare companies. Trends in cancer monoclonal antibody partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal ...  |  read more...
USD 1,995
Analytical Instruments: United States
8/1/2014 | published by: Freedonia Focus Reports
... terms of laboratory instruments, process control instruments, electrical measuring equipment, and other instruments. To illustrate historical trends, total demand and shipments are provided in annual series from 2003 to 2013; the various segments are reported ...  |  read more...
USD 600
Toscana Biomarkers Srl - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... probes for biomarkers identification. The company’s diagnostic tests include ELISA, multiplex assays on beads or chip, and point of care assays. It offers autoantibody blood tests, blood tests to measure inflammation and organ function, clinical ...  |  read more...
USD 750
Covance Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Agilent Technologies, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Vivia Biotech, S.L. - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... Vivia provides treatments for hematological cancers, such as leukemia, lymphoma and multiple myeloma. The company concentrates on personalized medicine test for hematologic cancers. Its technology platform consists of cytometry instruments. The company also has extended ...  |  read more...
USD 750
Global - miRNA Market Outlook to 2018
8/1/2014 | published by: RNCOS
... are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart Disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market ...  |  read more...
USD 1,400
China Cord Blood Corporation.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
2014 Market Research Report - Global Fibrin Glue Industry
7/28/2014 | published by: 9Dimen Research
... main region including North American, Europe and Asia etc, and the main country including United States, Germany, Japan and China etc. The report firstly introduced Fibrin Glue basic information including Fibrin Glue definition classification application ...  |  read more...
USD 2,850
WaferGen Bio:systems, Inc : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Cell Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer CropScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer MaterialScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Miltenyi Biotec GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/18/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Miltenyi Biotec GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
7/1/2014 | published by: Current Partnering
... into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter distribution deals. The majority of deals are multicomponent whereby the licensor offers a right ...  |  read more...
USD 3,295
Cesca Therapeutics, Inc. (formerly Thermogenesis Corp.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cesca Therapeutics, Inc. (formerly Thermogenesis Corp.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... SURVEYOR nuclease kits. Transgenomic offers equipments, reagents and other consumables that help in clinical and research applications in molecular testing and cytogenetics. Its pharmacogenomics service segment provides pharmacogenomics research services supporting phase II and phase ...  |  read more...
USD 750
Galapagos NV : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Generex Biotechnology Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
InterMune, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' InterMune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
1  2    4    6  7  8  9  10